Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone

NCT00597428 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

437

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid-Induced Bowel Dysfunction

Interventions

DRUG: Lubiprostone
DRUG: Placebo

Sponsor

Sucampo Pharma Americas, LLC

Collaborators

[object Object]